Archive · 27 Dec 2025
Virohan Raises ₹65 Crore for Global Healthcare Talent
Virohan is a company that teaches people to become healthcare workers.
They just got ₹65 crore from investors to help them teach more people and send trained workers to other countries like Japan and Germany.
There's a big need for healthcare workers around the world, and Virohan wants to help fill that gap.
They work with universities and healthcare companies to make sure their students get good jobs.
They've already taught over 13,000 people and are planning to expand to more parts of India and other countries.
Virohan wants to make money by growing bigger and is hoping to be profitable in a few years.
Virohan raised ₹65 crore in Series B funding led by Mynavi Corporation, with participation from Blume Ventures and existing investors.
The funding will be used to expand healthcare degree programs across India and build international placement corridors for Indian healthcare workers.
Virohan partners with over 20 universities and 2,000 healthcare employers, focusing on job readiness and employability.
The company is running pilot programs for international placements in Japan and Germany, with plans to expand to Europe, Australia, and other regions.
Virohan aims to achieve profitability by FY27–28, supported by unit-level profitability and operating leverage as scale increases.
- Who
- Virohan, a healthcare education startup
- What
- Raised ₹65 crore in Series B funding to expand healthcare education and international placements
- When
- Ongoing Series B round
- Where
- India, with plans to expand internationally to Japan, Germany, Europe, Australia
- Why
- To address the global shortage of healthcare professionals and position India as a key supplier
- Funding Amount
- ₹65 crore
- Lead Investor
- Mynavi Corporation
- Other Investors
- Blume Ventures, existing investors
- Founded
- 2018
- Universities Partnered
- Over 20
- Healthcare Employers Partnered
- Over 2,000
- Healthcare Professionals Trained
- Over 13,000
- Target Profitability
- FY27–28